The segment is impelled by the broad use and proven efficacy of various injectable formulations, including dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy), and liraglutide (Victoza, Saxenda) in managing type 2 diabetes and obesity
Different mechanisms, no overlap, and they seem to amplify each other's effects
Clinical Benefits Promotes delta wave activity and deep sleep stages where the most restorative physiological processes occur including physical recovery, immune optimization, and metabolic regulation
Clinical trials show that drugs like semaglutide can help people lose 15% or more of their body weight, while even the most intensive lifestyle interventions typically achieve 510% weight loss
Quick Facts HQ: Basel, Switzerland FY2024 Revenue: USD 51.7B FY2024 (+11% USD, +12% cc)